Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.12
+0.31 (6.44%)
At close: Mar 10, 2026, 4:00 PM EDT
5.25
+0.13 (2.54%)
After-hours: Mar 10, 2026, 7:45 PM EDT
Myriad Genetics Stock Forecast
Stock Price Forecast
The 7 analysts that cover Myriad Genetics stock have a consensus rating of "Buy" and an average price target of $7.64, which forecasts a 49.22% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $10.
Price Target: $7.64 (+49.22%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Myriad Genetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 9 | 9 | 5 | 5 |
| Sell | 3 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 14 | 14 | 14 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +17.19% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6.5 → $6 | Hold | Maintains | $6.5 → $6 | +17.19% | Feb 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8.5 | Buy | Maintains | $9 → $8.5 | +66.02% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | +26.95% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +75.78% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
883.76M
from 824.50M
Increased by 7.19%
Revenue Next Year
933.56M
from 883.76M
Increased by 5.64%
EPS This Year
0.06
from -3.95
EPS Next Year
0.19
from 0.06
Increased by 211.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 914.1M | 990.3M | |||
| Avg | 883.8M | 933.6M | |||
| Low | 842.8M | 876.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.9% | 12.1% | |||
| Avg | 7.2% | 5.6% | |||
| Low | 2.2% | -0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.23 | 0.43 | |||
| Avg | 0.06 | 0.19 | |||
| Low | -0.06 | 0.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 608.7% | |||
| Avg | - | 211.3% | |||
| Low | - | -51.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.